Welcome
Support Centre
12 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Effect of combined somatosensory stimulation and task specific training on upper limb function in chronic stroke patients
ISRCTN ISRCTN05542931
ClinicalTrials.gov identifier
Public title Effect of combined somatosensory stimulation and task specific training on upper limb function in chronic stroke patients
Scientific title Effect of combined somatosensory stimulation and task specific training on upper limb function in chronic stroke patients: a double blind randomised controlled trial
Acronym Sensory Stimulation
Serial number at source 7835
Study hypothesis Background:
After rehabilitation following a stroke many people recover the ability to walk without assistance, but are very limited in the activities of daily life because of poor recovery in their arm and hand. This loss of function may affect them and their carers and increase their dependency on health and social services. Recent research in both healthy and stroke subjects has indicated that low intensity electrical stimulation of the nerves in the arm, just strong enough to be felt, can lead to changes in the brain and its connection to the stimulated muscles with a resultant improvement in functional performance.

Aims:
We want to investigate whether this type of stimulation in combination with specific exercise training is better than exercises alone (the current clinical practice) for improving arm function and usage in stroke patients who have stopped improving with rehabilitation.

Subjects and methods:
We will carry out a double blind randomised controlled trial. We will recruit people aged 65 years and above who have had a stroke at least three months previously, and are not currently receiving rehabilitation, able to understand instructions and give consent for the study. Subjects will be randomly allocated to two groups to receive either of two packaged interventions. The intervention will take place three times weekly for four weeks at our laboratory located near London Bridge. We will also explore how the stimulation works using techniques which explore brain and movement function.

Outcome measures:
Several arm function tests such as task performance, strength etc in addition to brain function measurements will be assessed at the beginning, immediately after the training and for 6 months after the training at 3-monthly intervals.
Lay summary
Ethics approval Guy's Research Ethics Committee approved on the 27th October 2009 (ref: 09/H0804/87)
Study design Single centre randomised interventional treatment trial
Countries of recruitment United Kingdom
Disease/condition/study domain Topic: Stroke Research Network; Subtopic: Rehabilitation; Disease: Therapy type
Participants - inclusion criteria 1. At least 65 years of age, either sex
2. History of a single ischaemic stroke at least 3 months duration
3. Abbreviated Mental Test Score (AMT) greater than 7
4. Ambulant and able to attend the laboratory
5. Active range of shoulder elevation at least 60 degrees and 10 degrees of wrist extension
6. Passive pain free range of movement (ROM) of at least 75 % of normal in shoulder, elbow, wrist and hand
7.Presence of motor evoked potential (MEPs) in the hand muscles in response to TMS
Participants - exclusion criteria 1. Currently undergoing a stroke rehabilitation programme
2. Neurologic disorders or infarcts in the vertebrobasilar territory
3. Severe heart or lung disease
4. Severe aphasia (normal score on the Frenchay Aphasia Screening Test)
5. Visuospatial disorders (as screened by the Star cancellation test)
6. Metal in the head, seizures, auditory or cardiac implants, severe spasticity (defined as a score of greater than 3 on the Modified Ashworth Scale [MAS])
Anticipated start date 01/10/2009
Anticipated end date 30/09/2012
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants Planned sample size: 52; UK sample size: 52
Interventions Somatosensory stimulation will be delivered to three arm nerves (ulnar at the medial epicondylar groove of the elbow, median in front of the elbow joint and radial nerve above the lateral epicondyle) in the upper arm using three pairs of self adhesive electrodes (2.5 cm by 2.5 cm). It will be delivered in the laboratory for 2 hours, 3 times each week for 4 weeks using the following dose: 1 ms pulses at 10 Hz, 500 ms on and off. The amplitude will be approximately 3 times feeling threshold.
Primary outcome measure(s) Change in functional ability of the upper limb arm. Outcome measures will be assessed at beginning and end of the intervention (duration: 4 weeks) and then at 3 and 6 months follow up. A retest will be made within a week of the initial assessment and before the first treatment session in order to establish the stability of the baseline.
Secondary outcome measure(s) 1. Level of dependence in basic activities of daily living (Barthel Index)
2. Hand dexterity by the Block and Block test
3. Real life use of upper limb (Motor Activity Log)
4. Assessment of motor function by the upper limb motor function (FuglMeyer
Motor Assessment)
5. Health related quality of life (36-item Short Form [SF36])
6. Changes in upper limb movement trajectory by 3D motion analysis of upper limb funtion
7. Upper limb spasticity by the Modified Ashworth Scale and Tardieu Scale

Outcome measures will be assessed at beginning and end of the intervention (duration: 4 weeks) and then at 3 and 6 months follow up. A retest will be made within a week of the initial assessment and before the first treatment session in order to establish the stability of the baseline.
Sources of funding Dunhill Medical Trust (UK)
Trial website
Publications
Contact name Dr  Jeroen  Bergmann
  Address Kings College London
Strand
  City/town London
  Zip/Postcode WC2R 2LS
  Country United Kingdom
Sponsor Kings College London (UK)
  Address School of Social Sciences and Public Policy
  City/town London
  Zip/Postcode WC2R 2LS
  Country United Kingdom
  Sponsor website: http://www.kcl.ac.uk/
Date applied 12/05/2010
Last edited 18/05/2010
Date ISRCTN assigned 12/05/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central